
Quotient Limited announces FDA approval of seven blood bank reagents, including two market firsts
Quotient Limited (“Quotient”) (NASDAQ: QTNT), an established, commercial-stage diagnostics company, today announced the recent FDA approval for U.S. commercialisation of...